World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: REBEC
Last refreshed on: 29 April 2013
Main ID:  RBR-25tcrt
Date of registration: 01/05/2012
Primary sponsor: Universidade Federal de Ciências da Saúde de Porto Alegre - UFCSPA - Porto Alegre, RS, Brazil
Public title: Effects of electrical stimulation and ventilatory muscle training in patients with kidney disease on hemodialysis
Scientific title: Effects of functional electrical stimulation and inspiratory muscle training on quality of life and functional capacity of patients with end-stage renal disease on hemodialysis: a randomized clinical trial
Date of first enrolment: 10/03/2011
Target sample size: 60
Recruitment status: recruiting
URL:  http://www.ensaiosclinicos.gov.br/rg/RBR-25tcrt/
Study type: 
Study design:  Clinical trial, 4 groups, open, randomized controlled  
Countries of recruitment
Brazil
Contacts
Name: Thiago   Dipp
Address:  Rua Sarmento Leite, 245 90050-170 Porto Alegre Brazil
Telephone: +55 (51) 3303-9000
Email: thdipp@hotmail.com
Affiliation:  Universidade Federal de Ciências da Saúde de Porto Alegre - UFCSPA
Name: Rodrigo  Plentz
Address:  Sarmento Leite, 245 90050-170 Porto Alegre Brazil
Telephone: 4911062
Email: roplentz@yahoo.com.br
Affiliation:  Universidade Federal de Ciências da Saúde de Porto Alegre - UFCSPA
Key inclusion & exclusion criteria
Inclusion criteria: Patients with ESRD undergoing hemodialysis more than 3 months; Urea clearance during hemodialysis (Kt / V) > 1.2
Exclusion criteria: Patients with recent stroke, disabling osteoarticular or musculoskeletal disease, uncontrolled hypertension (SBP > 230mmHg and DBP > 120 mmHg), heart failure class III or IV according to the NYHA or decompensated, uncontrolled diabetes (glicaemia > 300 mg / dL), unstable angina, fever and / or infectious disease, acute respiratory failure; recent acute myocardial infarction (2 months), active smoking


Age minimum: 18Y
Age maximum: 80Y
Gender: -
Health Condition(s) or Problem(s) studied
End-stage renal disease
C12.777.419.780.750
E02.870.300
Intervention(s)
Functional Electrical Stimulation (n=15): FES will be applied at 15 Hz, 0.4 ms pulse width, 10-s contraction time, 50-s resting time and maximum tolerable intensity, 3 sessions per week, for 12 weeks. Extensor knee muscle will be stimulated.

Inspiratory muscle training (n=15): IMT will be performed for 12 weeks, 5 sessions per week, with an intensity of 30% of maximal inspiratory pressure

Functional electrical stimulation associated with inspiratory muscle training (FES + IMT n=15): will be held for 12 weeks, the EEF will be performed at first hour of haemodialysis and TMI in the patient's home.

Control (n=15): without intervention
Primary Outcome(s)
Functional capacity assessed by distance walked in 6-Minute Walk Test
Quality of life assessed by the questionnaire for kidney disease "Kidney Disease and Quality of Life - Short Form"
Secondary Outcome(s)
Autonomic control by frequency counter
Hand-grip strength by dynamometry
Lung function measured by spirometry
Oxidative stress
Percentage of body fat by skinfold
Peripheral muscle resistance assessed by the number of repetitions in Sit-to-Stand test
Respiratory muscle strength assessed by manometer
Secondary ID(s)
Irmandade da Santa Casa de Misericórdia de Porto Alegre
SISNEP
Universidade Federal de Ciências da Saúde de Porto Alegre - UFCSPA
Source(s) of Monetary Support
Universidade Federal de Ciências da Saúde de Porto Alegre - UFCSPA - Porto Alegre, RS, Brazil
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - Brasília, DF, Brazil
Secondary Sponsor(s)
Irmandade da Santa Casa de Misericórdia de Porto Alegre - Porto Alegre, RS, Brazil
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history